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Of the approximately 85,000 chemicals in use, 1000 have been identified as having the ability to disrupt normal endocrine function. Exposure to endocrine disrupting chemicals (EDCs) during critical period in brain differentiation (prenatal and neonatal life) via the mother can alter the course of the development of sexually dimorphic behaviors. Bisphenol A (BPA) is a very high volume chemical used in plastic, resins and other products, and virtually everyone examined has detectable BPA. BPA has estrogenic activity and is one of the most studied EDCs. We review evidence from studies in rodents using dose levels relevant to human exposure. BPA alters behavior and eliminates or in some cases reverses sexually dimorphic behaviors observed in unexposed animals.
Introduction
The Endocrine Society defines an endocrine disrupting chemical (EDC) as an exogenous chemical substance or chemical mixture that alters the structure or function(s) of the endocrine system [1] . Two main issues have clearly emerged from the past twenty years of experimental research on EDC effects in rodent models. The first is the issue of heightened vulnerability to EDC exposure during critical period in development (embryos, fetuses and newborns) [2] . Mothers can pass chemicals to their offspring transplacentally in mammals, and after birth by breastfeeding newborns. Second, EDCs cause effects at doses much lower than those used in traditional toxicological studies conducted for chemical risk assessments; these are referred to as 'low doses', that are below the lowest observed adverse effect level (LOAEL) in a traditional toxicological study. 'Low doses' can produce effects on organisms that are not predicted based on effects observed at very high doses [3] . These low-dose effects occur because natural hormones and EDCs can initiate responses in target tissues as a result of binding to a small proportion of available receptors and the recruitment of coactivators that amplify responses. Moreover, traditional toxicological endpoints, such as gene mutations, weight loss, altered organ weight and death, that are examined using very high doses far above the physiological range, are less sensitive than the functional endpoints examined in low-dose studies in developing organisms [3] . Similar to endogenous hormones, when a sufficient number of doses are examined, EDCs can result in non-monotonic dose-response curves through a variety of mechanisms [3] .
Animal studies have shown that prenatal exposure, via mothers' exposure to EDCs, produces postnatal adverse effects on multiple tissues and functions, including the brain and behavior. Altered behavior is a conspicuous endpoint produced by exposure to EDCs, with specific effects dependent on the developmental critical period, mechanism of action of the chemical, and sex, since there are sex differences in endocrine function during development as well as in adulthood. An EDC that has been shown to cause behavioral disturbances is bisphenol A (BPA), which will be the primary focus of this review, although, where appropriate, effects of other EDCs, such as phthalates or pesticides, on behavior will also be discussed. We have focused on BPA as a paradigmatic example of EDC's effects on behavioral development, because it is one of the most widely prevalent EDCs [4] , is present in a wide variety of commonly used products and applications, and there is strong evidence that BPA is a neuroendocrine disruptor and thus can interfere with sexual differentiation processes [5, 6] .
We discuss here the most relevant recent studies reporting the effects of prenatal (gestational) exposure to BPA at 'environmentally relevant doses' based on human biomonitoring studies [4] . The use of environmentally relevant doses as our focus here is more relevant to human health than the definition of 'low dose' identified above. Thus, in this review we discuss experimental studies involving maternal administration of doses of BPA equal to or below the reference (presumed safe) 
